These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 18216038

  • 1. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
    Villasante A, Pacheco A, Pau E, Ruiz A, Pellicer A, Garcia-Velasco JA.
    Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038
    [Abstract] [Full Text] [Related]

  • 2. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome.
    Pau E, Alonso-Muriel I, Gómez R, Novella E, Ruiz A, García-Velasco JA, Simón C, Pellicer A.
    Hum Reprod; 2006 Jun; 21(6):1453-60. PubMed ID: 16488907
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome.
    Griesinger G, Dafopoulos K, Schultze-Mosgau A, Jelkmann W, von Otte S, Diesing D, Diedrich K.
    Arch Gynecol Obstet; 2006 Apr; 274(1):29-33. PubMed ID: 16408189
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor production by circulating immune cells is elevated in ovarian hyperstimulation syndrome.
    Kosaka K, Fujiwara H, Yoshioka S, Fujii S.
    Hum Reprod; 2007 Jun; 22(6):1647-51. PubMed ID: 17356124
    [Abstract] [Full Text] [Related]

  • 10. [Preliminary study on the role of vascular endothelial growth factor in pathogenesis of ovarian hyperstimulation syndrome].
    Zhou C, Yu C, Zhuang G.
    Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):654-6. PubMed ID: 11930688
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A.
    Pietrowski D, Szabo L, Sator M, Just A, Egarter C.
    Hum Reprod; 2012 Jan; 27(1):196-9. PubMed ID: 22016416
    [Abstract] [Full Text] [Related]

  • 13. Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways.
    Chen SU, Chou CH, Lin CW, Lee H, Wu JC, Lu HF, Chen CD, Yang YS.
    Hum Reprod; 2010 Mar; 25(3):757-67. PubMed ID: 20008399
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effects of 'coasting' on follicular fluid concentrations of vascular endothelial growth factor in women at risk of developing ovarian hyperstimulation syndrome.
    Tozer AJ, Iles RK, Iammarrone E, Gillott CM, Al-Shawaf T, Grudzinskas JG.
    Hum Reprod; 2004 Mar; 19(3):522-8. PubMed ID: 14998945
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serum leptin concentrations in patients with severe ovarian hyperstimulation syndrome during in vitro fertilization-embryo transfer treatment.
    Ayustawati, Shibahara H, Hirano Y, Suzuki T, Takamizawa S, Suzuki M.
    Fertil Steril; 2004 Sep; 82(3):579-85. PubMed ID: 15374699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.